← Back to Search

Osteopathic Manipulative Treatment for Headache

N/A
Waitlist Available
Led By Genevieve McGerald, DO
Research Sponsored by Good Samaritan Hospital Medical Center, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients will be triaged to the appropriate part of the Emergency Department in the usual fashion. A healthcare provider will evaluate the patient and if the patient's chief complaint is headache the provider will determine if they are a candidate for the study utilizing
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately before and after intervention (less than 30 minutes)
Awards & highlights

Study Summary

PURPOSE The purpose of this research is to determine whether osteopathic manipulative therapy (OMT) is a useful adjunct in evaluation and treatment of headaches. PROCEDURES If a practitioner determines that a patient has a significant headache he/she may order tests. He/ She may give the patient medications to treat the headache. The investigators will also ask permission to evaluate and treat the headache using osteopathic evaluation and Osteopathic Manipulative Treatment (OMT). The bedside evaluation and treatment will be performed by an emergency medicine resident. Osteopathic evaluation and OMT is not standard of care for this condition. The investigators also may call the patient in 7 days to see how they are doing. The investigators wish to see if emergency medicine physicians can use osteopathic evaluation and OMT to reliably treat headaches. The results of the examination and treatment will be recorded, but will not be used to change treatment or to change additional tests. The investigators wish to see whether in the future they can use OMT in certain cases instead of or in conjunction with medications. The investigators plan on asking 50 patients to participate.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately before and after intervention (less than 30 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately before and after intervention (less than 30 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Headache Pain as Measured by a VAS

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Osteopathic Manipulative TreatmentExperimental Treatment1 Intervention
The osteopathic treatment group will have performed on them 3 standardized osteopathic manipulative treatments. If at any time the patient is unable to tolerate a treatment secondary to pain that particular study will be stopped. If the patient's nurse enters the room with medication, the study will be stopped and patient will not be included in the study. At no time will the patient's medical treatment in the emergency department be delayed to perform OMT
Group II: Sham Osteopathic Manipulative TreatmentPlacebo Group1 Intervention
The sham group will receive 3 sham treatments. If at any time the patient is unable to tolerate a treatment secondary to pain that particular study will be stopped. If the patient's nurse enters the room with medication, the study will be stopped and patient will not be included in the study. At no time will the patient's medical treatment in the emergency department be delayed to perform OMT.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Osteopathic Manipulative Treatment
2008
Completed Phase 4
~2530

Find a Location

Who is running the clinical trial?

Good Samaritan Hospital Medical Center, New YorkLead Sponsor
5 Previous Clinical Trials
6,830 Total Patients Enrolled
Genevieve McGerald, DOPrincipal InvestigatorGood Samaritan Hospital Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025